Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.15.745022

Serum preprocessing workflows differentially shape biological readout in data-independent acquisition proteomics of systemic juvenile idiopathic arthritis

Abstract

Serum proteomics is increasingly used for minimally invasive biomarker discovery and disease phenotyping, and the choice of serum preprocessing workflow can shape proteome depth, quantitative characteristics, and downstream biological readouts. However, disease-oriented comparisons within a single cohort remain limited. Here, we compared four serum preprocessing workflows--Top14 depletion (TOP14D), tomato lectin affinity purification (TomAP), and two nanoparticle-based enrichment workflows (NPA and NPB)--using serum from six patients with systemic juvenile idiopathic arthritis (sJIA) and six age- and sex-matched healthy controls, and analyzed them using unified data-independent acquisition mass spectrometry (DIA-MS) and a statistical pipeline. We evaluated proteome depth, missingness, quantitative characteristics, group separation, differential abundance signatures, pathway enrichment, curated sJIA-related gene set coverage, pre-ranked gene set enrichment analysis (GSEA) results, and detection of inflammasome/interferon-related proteins. TomAP yielded the greatest proteome depth (7612 proteins), followed by NPB (6735 proteins) and NPA (6602 proteins), whereas TOP14D yielded the smallest protein set (3303 proteins). Principal component analysis (PCA) showed a separation between the sJIA and control groups for all workflows. Differentially expressed proteins (DEPs) showed limited overlap, with only 75 DEPs common to all four workflows. Functional enrichment patterns were workflow-dependent; TOP14D and TomAP mainly captured neutrophil/myeloid and inflammatory processes, whereas NPA and NPB captured RNA processing- and translation-related signals. TomAP showed relatively broad coverage and positive enrichment of curated sJIA-related gene sets associated with inflammation, innate immunity, and macrophage activation syndrome (MAS). Inflammasome/interferon-related proteins, including NLRC4, PYCARD, GSDMD, MEFV, IL-18, OAS3, and MYD88, showed workflow-dependent detectability and differential abundance. These findings support a disease-oriented benchmark for fit-for-purpose workflow selection according to the disease axis and analytical objective rather than proteome depth alone.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sato, H., Akioka, S., Konno, R., Okuda, Y., Ohara, O., Kawashima, Y.. 2026-08-19. Serum preprocessing workflows differentially shape biological readout in data-independent acquisition proteomics of systemic juvenile idiopathic arthritis. https://doi.org/10.64898/2026.08.15.745022

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Deep reinforcement learning-driven discovery of a MsbA-targeted small-molecule antibiotic for the treatment of Acinetobacter baumannii infection

Antibiotics with new mechanisms are highly pursued to address the threat of infections caused by drug-resistant Gram-negative bacteria. Targeting MsbA, a key protein of the lipopolysaccharide biosynthesis pathway, represents a promising strategy to discover new classes of antibiotics. However, currently available MsbA-targeted molecules either lack sufficient potency or have unfavorable properties, necessitating expansion of chemical space. In this study, we chose the most promising cerastecin Cpd 4 as the template, and used two Artificial Intelligence (AI)-based tools, i.e. Link-INVENT and AutoMolDesigner for molecular design, performed chemical derivatization and antibacterial activity evaluation, which led to the discovery of Y-11 (MIC for A. baumannii: 0.5 g/mL). Encouragingly, Y-11 showed equivalent potency to Cpd4 for carbapenem-resistant A. baumannii, and less cytotoxicity and hemolysis as well as lower spontaneous resistance frequency. In vivo efficacy study demonstrated that Y-11 could effectively reduce bacterial loads in the mice infected by A. baumannii. The following mechanism study including molecular dynamics simulation, biochemical assay, and transmission electron microscope (TEM) analysis suggested that Y-11 inhibited the transport of lipooligosaccharide and impaired the formation of outer membrane, probably by competitively binding to the substrate binding site of MsbA and modulating ATPase activity. Taken together, we have discovered a MsbA-targeted small molecule Y-11 via AI-driven drug design, which provides a foundation for future antibiotic development.

biochemistry↗

Dynamic architecture of the Rixosome reveals mechanism of activation and ITS2 processing

Eukaryotic ribosome assembly requires the coordinated processing and extensive remodeling of pre-rRNAs. During late nuclear maturation of the 60S subunit, sequential removal of the internal transcribed spacer 2 (ITS2) is initiated by endonucleolytic cleavage at site C2 by the conserved Las1 nuclease. Las1 acts together with the kinase Grc3 and the Rix1 complex to form the Rixosome, which also functions in transcriptional regulation. However, the assembly of the Rixosome, its recruitment to pre-ribosomes, and its activation for ITS2 cleavage remain unclear. Here, we present cryo-EM structures of the human LAS1 complex, two structures of the isolated Rixosome and nine transition states of Rix1-bound pre-60S particles from Schizosaccharomyces pombe. These structures reveal a dynamic Rixosome architecture in which the heterotetrameric Las1 complex engages one or two copies of the Rix1 complex. Rix1 binding is highly flexible in the human Rixosome but rigid in the yeast complex. The isolated yeast Rixosome remains inactive, but binding to the pre-60S particle triggers a structural rearrangement that allows for substrate engagement and activation of the nuclease. Together, our results define the dynamic architecture of the Rixosome and provide a structural framework for ITS2 processing during nuclear maturation of the eukaryotic 60S ribosomal subunit.

biochemistry↗

SGFP-Grid Split GFP Graphene Grids

Affinity graphene grids provide a promising approach for selective protein capture in cryo-EM. Here, we introduce a split-GFP graphene grid platform(SGFP-G), in which graphene-conjugated GFP 1-10 selectively captures GFP11 tagged proteins from low concentration samples or cell lysates. This platform enables rapid assessment of target protein enrichment and particle distribution before vitrification via fluorescence imaging, while the grid design positions captured proteins away from the graphene surface and air-water interface. We also introduce a unique strategy to minimize nonspecific protein adsorption, thereby improving the selective enrichment of target proteins on this grid. Using GFP11-tagged apoferritin, we demonstrate fluorescence guided protein capture and obtain a 2.58 [A] cryoEM reconstruction, establishing SGFP-G as an affinity grid platform for high resolution structural studies with reduced sample requirements.

biochemistry↗